Krsnaa Diagnostics Board approves INR 430 crore NCD issue
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved issuance of 43,000 unlisted secured NCDs of face value INR 1 lakh each, totalling up to INR 430 crore, via private placement. Tenure is 7 years with a fixed rate coupon (rate not disclosed). The NCDs will be redeemed in 13 equal half-yearly instalments starting 6 months after allotment, and are secured by a charge over company assets. The NCDs are unrated and will not be listed.
Company raising INR 430 crore via secured debt; no equity dilution but will increase interest costs. Funds likely support business expansion.